Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
New methods for the laboratory-scale synthesis of coumarin-based drugs were developed in a recent study completed at the University of Eastern Finland. In his doctoral thesis, Lic. Phil. Juri Timonen also developed new analytical methods for the fast identification of natural and non-natural coumarins. A few of the synthesised coumarins were also found to inhibit some specific reactions generally associated with inflammation.
Coumarin is an aromatic compound, naturally occurring in many plants. In foodstuffs coumarins are found especially in cinnamon and tonka beans. The bioactivity of coumarins has been utilised in many drugs; for example, coumarins exhibit anti-inflammatory as well as anticoagulant activities. One of the best-known drugs based on a coumarin scaffold is Marewan®, a commercial blood anticoagulant.
The study made considerable improvements to the decades-old synthesis method of coumarins. Most of the previous methods are based on heating of the starting material with a strong acid, but the newly developed method also works at room temperature. The improvements also lower the production costs, since the final products are easier to purify.
A commonly used inflammation model showed that some of the synthesised coumarins remarkably reduced the production of typical signalling molecules, such as nitric oxide synthase and nitric oxide itself, which are usually linked to inflammation. In this assay, a murine cell line from mice imitated the inflammatory response. The results also revealed one of the pathways in which coumarins act. Understanding of this pathway and data on nearly 50 tested coumarins may help in the development of future anti-inflammatory drugs for chronic inflammation diseases such as asthma and rheumatoid arthritis.
Developing new analytical methods for natural and non-natural compounds is important in the screening of natural products with biological activity as well as in studies of drug metabolism. By using a mass spectrometric method developed in this study, even very similar compounds can be distinguished and characterized based on their fragmentation during the analysis.
A fragmentation pattern for a given molecule obtained by a mass spectrometer resembles a fingerprint; it is dependent only on the structure of the molecule and two non-identical molecules produce different patterns. The study revealed some interesting details on the fragmentation of synthesized coumarins. This knowledge can be used in the future to predict fragmentation of novel coumarins.
The findings were originally published in European Journal of Medical Chemistry, European Journal of Mass Spectrometry, and Rapid Communications in Mass Spectrometry.
Timonen, J. M.; Nieminen, R. M.; Sareila, O.; Goulas, A.; Moilanen, L. J.; Haukka, M.; Vainiotalo, P.; Moilanen, E.; Aulaskari, P. H.; Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives, Eur. J. Med. Chem. 2011, 46, pp. 3845-50.
Timonen, J.; Aulaskari, P.; Hirva, P.; Vainiotalo, P.; Negative ion electrospray ionization mass spectrometry and computational studies on substituted 7-hydroxycoumarins, Eur. J. Mass Spectrom. 2009, 15, pp. 595-603.
Timonen, J.; Romppanen, R.; Aulaskari, P.; Jänis, J.; Low-energy collision induced dissociation tandem mass spectrometry of 7-acetonyloxycoumarins, Rapid Commun. Mass Spectrom. 2013, 27, pp. 2665-2675.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Immune System / Vaccines category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Eastern Finland. "Future anti-inflammatory drugs for chronic inflammation diseases may come from coumarins." Medical News Today. MediLexicon, Intl., 27 Nov. 2013. Web.
24 Apr. 2014. <http://www.medicalnewstoday.com/releases/269374>
University of Eastern Finland. (2013, November 27). "Future anti-inflammatory drugs for chronic inflammation diseases may come from coumarins." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269374.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.